Global Quadrivalent Meningococcal Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Quadrivalent Meningococcal Vaccine market size was valued at USD 190.4 million in 2022 and is forecast to a readjusted size of USD 279.3 million by 2029 with a CAGR of 5.6% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Many countries have implemented meningococcal vaccination programs, especially targeting high-risk groups such as infants, adolescents and university students. Inclusion or recommendation of quadrivalent meningococcal vaccines in national immunization schedules can significantly influence the market demand.
The meningococcal quadrivalent vaccine protects against 4 types of meningococcus: types A, C, Y, and W.
This report is a detailed and comprehensive analysis for global Quadrivalent Meningococcal Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Quadrivalent Meningococcal Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Quadrivalent Meningococcal Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Quadrivalent Meningococcal Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Quadrivalent Meningococcal Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Quadrivalent Meningococcal Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Quadrivalent Meningococcal Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi-Pasteur, Walvax, Chengdu Kanghua Biological Products Co., Ltd., Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. and Zhejiang Tianyuan Biopharmaceutical Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Quadrivalent Meningococcal Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Quadrivalent Meningococcal Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Quadrivalent Meningococcal Vaccine, with price, sales, revenue and global market share of Quadrivalent Meningococcal Vaccine from 2018 to 2023.
Chapter 3, the Quadrivalent Meningococcal Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Quadrivalent Meningococcal Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Quadrivalent Meningococcal Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Quadrivalent Meningococcal Vaccine.
Chapter 14 and 15, to describe Quadrivalent Meningococcal Vaccine sales channel, distributors, customers, research findings and conclusion.
Many countries have implemented meningococcal vaccination programs, especially targeting high-risk groups such as infants, adolescents and university students. Inclusion or recommendation of quadrivalent meningococcal vaccines in national immunization schedules can significantly influence the market demand.
The meningococcal quadrivalent vaccine protects against 4 types of meningococcus: types A, C, Y, and W.
This report is a detailed and comprehensive analysis for global Quadrivalent Meningococcal Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Quadrivalent Meningococcal Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Quadrivalent Meningococcal Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Quadrivalent Meningococcal Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Quadrivalent Meningococcal Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Quadrivalent Meningococcal Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Quadrivalent Meningococcal Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi-Pasteur, Walvax, Chengdu Kanghua Biological Products Co., Ltd., Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. and Zhejiang Tianyuan Biopharmaceutical Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Quadrivalent Meningococcal Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Polysaccharide Vaccine
- Conjugate Vaccine
- Hospital
- Clinic
- Sanofi-Pasteur
- Walvax
- Chengdu Kanghua Biological Products Co., Ltd.
- Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.
- Zhejiang Tianyuan Biopharmaceutical Co., Ltd.
- Beijing Institute of Biological Products Co., Ltd.
- CanSino Biological Co., Ltd.
- Hualan Biological Vaccine Co., Ltd.
- Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Quadrivalent Meningococcal Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Quadrivalent Meningococcal Vaccine, with price, sales, revenue and global market share of Quadrivalent Meningococcal Vaccine from 2018 to 2023.
Chapter 3, the Quadrivalent Meningococcal Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Quadrivalent Meningococcal Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Quadrivalent Meningococcal Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Quadrivalent Meningococcal Vaccine.
Chapter 14 and 15, to describe Quadrivalent Meningococcal Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Quadrivalent Meningococcal Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Quadrivalent Meningococcal Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Polysaccharide Vaccine
1.3.3 Conjugate Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Quadrivalent Meningococcal Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Quadrivalent Meningococcal Vaccine Market Size & Forecast
1.5.1 Global Quadrivalent Meningococcal Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Quadrivalent Meningococcal Vaccine Sales Quantity (2018-2029)
1.5.3 Global Quadrivalent Meningococcal Vaccine Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Sanofi-Pasteur
2.1.1 Sanofi-Pasteur Details
2.1.2 Sanofi-Pasteur Major Business
2.1.3 Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Product and Services
2.1.4 Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi-Pasteur Recent Developments/Updates
2.2 Walvax
2.2.1 Walvax Details
2.2.2 Walvax Major Business
2.2.3 Walvax Quadrivalent Meningococcal Vaccine Product and Services
2.2.4 Walvax Quadrivalent Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Walvax Recent Developments/Updates
2.3 Chengdu Kanghua Biological Products Co., Ltd.
2.3.1 Chengdu Kanghua Biological Products Co., Ltd. Details
2.3.2 Chengdu Kanghua Biological Products Co., Ltd. Major Business
2.3.3 Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
2.3.4 Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Chengdu Kanghua Biological Products Co., Ltd. Recent Developments/Updates
2.4 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.
2.4.1 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Details
2.4.2 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Major Business
2.4.3 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
2.4.4 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Recent Developments/Updates
2.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd.
2.5.1 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Details
2.5.2 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Major Business
2.5.3 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
2.5.4 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Recent Developments/Updates
2.6 Beijing Institute of Biological Products Co., Ltd.
2.6.1 Beijing Institute of Biological Products Co., Ltd. Details
2.6.2 Beijing Institute of Biological Products Co., Ltd. Major Business
2.6.3 Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
2.6.4 Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Beijing Institute of Biological Products Co., Ltd. Recent Developments/Updates
2.7 CanSino Biological Co., Ltd.
2.7.1 CanSino Biological Co., Ltd. Details
2.7.2 CanSino Biological Co., Ltd. Major Business
2.7.3 CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
2.7.4 CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 CanSino Biological Co., Ltd. Recent Developments/Updates
2.8 Hualan Biological Vaccine Co., Ltd.
2.8.1 Hualan Biological Vaccine Co., Ltd. Details
2.8.2 Hualan Biological Vaccine Co., Ltd. Major Business
2.8.3 Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
2.8.4 Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Hualan Biological Vaccine Co., Ltd. Recent Developments/Updates
2.9 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.
2.9.1 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Details
2.9.2 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Major Business
2.9.3 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
2.9.4 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: QUADRIVALENT MENINGOCOCCAL VACCINE BY MANUFACTURER
3.1 Global Quadrivalent Meningococcal Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Quadrivalent Meningococcal Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Quadrivalent Meningococcal Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Quadrivalent Meningococcal Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Quadrivalent Meningococcal Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Quadrivalent Meningococcal Vaccine Manufacturer Market Share in 2022
3.5 Quadrivalent Meningococcal Vaccine Market: Overall Company Footprint Analysis
3.5.1 Quadrivalent Meningococcal Vaccine Market: Region Footprint
3.5.2 Quadrivalent Meningococcal Vaccine Market: Company Product Type Footprint
3.5.3 Quadrivalent Meningococcal Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Quadrivalent Meningococcal Vaccine Market Size by Region
4.1.1 Global Quadrivalent Meningococcal Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Quadrivalent Meningococcal Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Quadrivalent Meningococcal Vaccine Average Price by Region (2018-2029)
4.2 North America Quadrivalent Meningococcal Vaccine Consumption Value (2018-2029)
4.3 Europe Quadrivalent Meningococcal Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Quadrivalent Meningococcal Vaccine Consumption Value (2018-2029)
4.5 South America Quadrivalent Meningococcal Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Quadrivalent Meningococcal Vaccine Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Quadrivalent Meningococcal Vaccine Consumption Value by Type (2018-2029)
5.3 Global Quadrivalent Meningococcal Vaccine Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Quadrivalent Meningococcal Vaccine Consumption Value by Application (2018-2029)
6.3 Global Quadrivalent Meningococcal Vaccine Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Quadrivalent Meningococcal Vaccine Market Size by Country
7.3.1 North America Quadrivalent Meningococcal Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Quadrivalent Meningococcal Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Quadrivalent Meningococcal Vaccine Market Size by Country
8.3.1 Europe Quadrivalent Meningococcal Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Quadrivalent Meningococcal Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Quadrivalent Meningococcal Vaccine Market Size by Region
9.3.1 Asia-Pacific Quadrivalent Meningococcal Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Quadrivalent Meningococcal Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Quadrivalent Meningococcal Vaccine Market Size by Country
10.3.1 South America Quadrivalent Meningococcal Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Quadrivalent Meningococcal Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Quadrivalent Meningococcal Vaccine Market Size by Country
11.3.1 Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Quadrivalent Meningococcal Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Quadrivalent Meningococcal Vaccine Market Drivers
12.2 Quadrivalent Meningococcal Vaccine Market Restraints
12.3 Quadrivalent Meningococcal Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Quadrivalent Meningococcal Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Quadrivalent Meningococcal Vaccine
13.3 Quadrivalent Meningococcal Vaccine Production Process
13.4 Quadrivalent Meningococcal Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Quadrivalent Meningococcal Vaccine Typical Distributors
14.3 Quadrivalent Meningococcal Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Quadrivalent Meningococcal Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Quadrivalent Meningococcal Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Polysaccharide Vaccine
1.3.3 Conjugate Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Quadrivalent Meningococcal Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Quadrivalent Meningococcal Vaccine Market Size & Forecast
1.5.1 Global Quadrivalent Meningococcal Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Quadrivalent Meningococcal Vaccine Sales Quantity (2018-2029)
1.5.3 Global Quadrivalent Meningococcal Vaccine Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Sanofi-Pasteur
2.1.1 Sanofi-Pasteur Details
2.1.2 Sanofi-Pasteur Major Business
2.1.3 Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Product and Services
2.1.4 Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi-Pasteur Recent Developments/Updates
2.2 Walvax
2.2.1 Walvax Details
2.2.2 Walvax Major Business
2.2.3 Walvax Quadrivalent Meningococcal Vaccine Product and Services
2.2.4 Walvax Quadrivalent Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Walvax Recent Developments/Updates
2.3 Chengdu Kanghua Biological Products Co., Ltd.
2.3.1 Chengdu Kanghua Biological Products Co., Ltd. Details
2.3.2 Chengdu Kanghua Biological Products Co., Ltd. Major Business
2.3.3 Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
2.3.4 Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Chengdu Kanghua Biological Products Co., Ltd. Recent Developments/Updates
2.4 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.
2.4.1 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Details
2.4.2 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Major Business
2.4.3 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
2.4.4 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Recent Developments/Updates
2.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd.
2.5.1 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Details
2.5.2 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Major Business
2.5.3 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
2.5.4 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Recent Developments/Updates
2.6 Beijing Institute of Biological Products Co., Ltd.
2.6.1 Beijing Institute of Biological Products Co., Ltd. Details
2.6.2 Beijing Institute of Biological Products Co., Ltd. Major Business
2.6.3 Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
2.6.4 Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Beijing Institute of Biological Products Co., Ltd. Recent Developments/Updates
2.7 CanSino Biological Co., Ltd.
2.7.1 CanSino Biological Co., Ltd. Details
2.7.2 CanSino Biological Co., Ltd. Major Business
2.7.3 CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
2.7.4 CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 CanSino Biological Co., Ltd. Recent Developments/Updates
2.8 Hualan Biological Vaccine Co., Ltd.
2.8.1 Hualan Biological Vaccine Co., Ltd. Details
2.8.2 Hualan Biological Vaccine Co., Ltd. Major Business
2.8.3 Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
2.8.4 Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Hualan Biological Vaccine Co., Ltd. Recent Developments/Updates
2.9 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.
2.9.1 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Details
2.9.2 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Major Business
2.9.3 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
2.9.4 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: QUADRIVALENT MENINGOCOCCAL VACCINE BY MANUFACTURER
3.1 Global Quadrivalent Meningococcal Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Quadrivalent Meningococcal Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Quadrivalent Meningococcal Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Quadrivalent Meningococcal Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Quadrivalent Meningococcal Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Quadrivalent Meningococcal Vaccine Manufacturer Market Share in 2022
3.5 Quadrivalent Meningococcal Vaccine Market: Overall Company Footprint Analysis
3.5.1 Quadrivalent Meningococcal Vaccine Market: Region Footprint
3.5.2 Quadrivalent Meningococcal Vaccine Market: Company Product Type Footprint
3.5.3 Quadrivalent Meningococcal Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Quadrivalent Meningococcal Vaccine Market Size by Region
4.1.1 Global Quadrivalent Meningococcal Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Quadrivalent Meningococcal Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Quadrivalent Meningococcal Vaccine Average Price by Region (2018-2029)
4.2 North America Quadrivalent Meningococcal Vaccine Consumption Value (2018-2029)
4.3 Europe Quadrivalent Meningococcal Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Quadrivalent Meningococcal Vaccine Consumption Value (2018-2029)
4.5 South America Quadrivalent Meningococcal Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Quadrivalent Meningococcal Vaccine Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Quadrivalent Meningococcal Vaccine Consumption Value by Type (2018-2029)
5.3 Global Quadrivalent Meningococcal Vaccine Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Quadrivalent Meningococcal Vaccine Consumption Value by Application (2018-2029)
6.3 Global Quadrivalent Meningococcal Vaccine Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Quadrivalent Meningococcal Vaccine Market Size by Country
7.3.1 North America Quadrivalent Meningococcal Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Quadrivalent Meningococcal Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Quadrivalent Meningococcal Vaccine Market Size by Country
8.3.1 Europe Quadrivalent Meningococcal Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Quadrivalent Meningococcal Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Quadrivalent Meningococcal Vaccine Market Size by Region
9.3.1 Asia-Pacific Quadrivalent Meningococcal Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Quadrivalent Meningococcal Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Quadrivalent Meningococcal Vaccine Market Size by Country
10.3.1 South America Quadrivalent Meningococcal Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Quadrivalent Meningococcal Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Quadrivalent Meningococcal Vaccine Market Size by Country
11.3.1 Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Quadrivalent Meningococcal Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Quadrivalent Meningococcal Vaccine Market Drivers
12.2 Quadrivalent Meningococcal Vaccine Market Restraints
12.3 Quadrivalent Meningococcal Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Quadrivalent Meningococcal Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Quadrivalent Meningococcal Vaccine
13.3 Quadrivalent Meningococcal Vaccine Production Process
13.4 Quadrivalent Meningococcal Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Quadrivalent Meningococcal Vaccine Typical Distributors
14.3 Quadrivalent Meningococcal Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Quadrivalent Meningococcal Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Quadrivalent Meningococcal Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Sanofi-Pasteur Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi-Pasteur Major Business
Table 5. Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Product and Services
Table 6. Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Sanofi-Pasteur Recent Developments/Updates
Table 8. Walvax Basic Information, Manufacturing Base and Competitors
Table 9. Walvax Major Business
Table 10. Walvax Quadrivalent Meningococcal Vaccine Product and Services
Table 11. Walvax Quadrivalent Meningococcal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Walvax Recent Developments/Updates
Table 13. Chengdu Kanghua Biological Products Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 14. Chengdu Kanghua Biological Products Co., Ltd. Major Business
Table 15. Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
Table 16. Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Chengdu Kanghua Biological Products Co., Ltd. Recent Developments/Updates
Table 18. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 19. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Major Business
Table 20. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
Table 21. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 23. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Major Business
Table 25. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
Table 26. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 28. Beijing Institute of Biological Products Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 29. Beijing Institute of Biological Products Co., Ltd. Major Business
Table 30. Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
Table 31. Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Beijing Institute of Biological Products Co., Ltd. Recent Developments/Updates
Table 33. CanSino Biological Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 34. CanSino Biological Co., Ltd. Major Business
Table 35. CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
Table 36. CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. CanSino Biological Co., Ltd. Recent Developments/Updates
Table 38. Hualan Biological Vaccine Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 39. Hualan Biological Vaccine Co., Ltd. Major Business
Table 40. Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
Table 41. Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Hualan Biological Vaccine Co., Ltd. Recent Developments/Updates
Table 43. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 44. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Major Business
Table 45. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
Table 46. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Recent Developments/Updates
Table 48. Global Quadrivalent Meningococcal Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 49. Global Quadrivalent Meningococcal Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 50. Global Quadrivalent Meningococcal Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 51. Market Position of Manufacturers in Quadrivalent Meningococcal Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 52. Head Office and Quadrivalent Meningococcal Vaccine Production Site of Key Manufacturer
Table 53. Quadrivalent Meningococcal Vaccine Market: Company Product Type Footprint
Table 54. Quadrivalent Meningococcal Vaccine Market: Company Product Application Footprint
Table 55. Quadrivalent Meningococcal Vaccine New Market Entrants and Barriers to Market Entry
Table 56. Quadrivalent Meningococcal Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Quadrivalent Meningococcal Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 58. Global Quadrivalent Meningococcal Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 59. Global Quadrivalent Meningococcal Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 60. Global Quadrivalent Meningococcal Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 61. Global Quadrivalent Meningococcal Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 62. Global Quadrivalent Meningococcal Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 63. Global Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 64. Global Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 65. Global Quadrivalent Meningococcal Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 66. Global Quadrivalent Meningococcal Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 67. Global Quadrivalent Meningococcal Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 68. Global Quadrivalent Meningococcal Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 69. Global Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 70. Global Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 71. Global Quadrivalent Meningococcal Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 72. Global Quadrivalent Meningococcal Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 73. Global Quadrivalent Meningococcal Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 74. Global Quadrivalent Meningococcal Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 75. North America Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 76. North America Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 77. North America Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 78. North America Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 79. North America Quadrivalent Meningococcal Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 80. North America Quadrivalent Meningococcal Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 81. North America Quadrivalent Meningococcal Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 82. North America Quadrivalent Meningococcal Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 83. Europe Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 84. Europe Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 85. Europe Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 86. Europe Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 87. Europe Quadrivalent Meningococcal Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 88. Europe Quadrivalent Meningococcal Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 89. Europe Quadrivalent Meningococcal Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Quadrivalent Meningococcal Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 92. Asia-Pacific Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 93. Asia-Pacific Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 94. Asia-Pacific Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 95. Asia-Pacific Quadrivalent Meningococcal Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 96. Asia-Pacific Quadrivalent Meningococcal Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 97. Asia-Pacific Quadrivalent Meningococcal Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 98. Asia-Pacific Quadrivalent Meningococcal Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 99. South America Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 100. South America Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 101. South America Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 102. South America Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 103. South America Quadrivalent Meningococcal Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 104. South America Quadrivalent Meningococcal Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 105. South America Quadrivalent Meningococcal Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 106. South America Quadrivalent Meningococcal Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 107. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 108. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 109. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 110. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 111. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 112. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 113. Middle East & Africa Quadrivalent Meningococcal Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 114. Middle East & Africa Quadrivalent Meningococcal Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 115. Quadrivalent Meningococcal Vaccine Raw Material
Table 116. Key Manufacturers of Quadrivalent Meningococcal Vaccine Raw Materials
Table 117. Quadrivalent Meningococcal Vaccine Typical Distributors
Table 118. Quadrivalent Meningococcal Vaccine Typical Customers
Table 1. Global Quadrivalent Meningococcal Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Quadrivalent Meningococcal Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Sanofi-Pasteur Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi-Pasteur Major Business
Table 5. Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Product and Services
Table 6. Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Sanofi-Pasteur Recent Developments/Updates
Table 8. Walvax Basic Information, Manufacturing Base and Competitors
Table 9. Walvax Major Business
Table 10. Walvax Quadrivalent Meningococcal Vaccine Product and Services
Table 11. Walvax Quadrivalent Meningococcal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Walvax Recent Developments/Updates
Table 13. Chengdu Kanghua Biological Products Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 14. Chengdu Kanghua Biological Products Co., Ltd. Major Business
Table 15. Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
Table 16. Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Chengdu Kanghua Biological Products Co., Ltd. Recent Developments/Updates
Table 18. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 19. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Major Business
Table 20. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
Table 21. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 23. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Major Business
Table 25. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
Table 26. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 28. Beijing Institute of Biological Products Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 29. Beijing Institute of Biological Products Co., Ltd. Major Business
Table 30. Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
Table 31. Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Beijing Institute of Biological Products Co., Ltd. Recent Developments/Updates
Table 33. CanSino Biological Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 34. CanSino Biological Co., Ltd. Major Business
Table 35. CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
Table 36. CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. CanSino Biological Co., Ltd. Recent Developments/Updates
Table 38. Hualan Biological Vaccine Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 39. Hualan Biological Vaccine Co., Ltd. Major Business
Table 40. Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
Table 41. Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Hualan Biological Vaccine Co., Ltd. Recent Developments/Updates
Table 43. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 44. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Major Business
Table 45. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
Table 46. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Recent Developments/Updates
Table 48. Global Quadrivalent Meningococcal Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 49. Global Quadrivalent Meningococcal Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 50. Global Quadrivalent Meningococcal Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 51. Market Position of Manufacturers in Quadrivalent Meningococcal Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 52. Head Office and Quadrivalent Meningococcal Vaccine Production Site of Key Manufacturer
Table 53. Quadrivalent Meningococcal Vaccine Market: Company Product Type Footprint
Table 54. Quadrivalent Meningococcal Vaccine Market: Company Product Application Footprint
Table 55. Quadrivalent Meningococcal Vaccine New Market Entrants and Barriers to Market Entry
Table 56. Quadrivalent Meningococcal Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Quadrivalent Meningococcal Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 58. Global Quadrivalent Meningococcal Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 59. Global Quadrivalent Meningococcal Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 60. Global Quadrivalent Meningococcal Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 61. Global Quadrivalent Meningococcal Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 62. Global Quadrivalent Meningococcal Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 63. Global Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 64. Global Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 65. Global Quadrivalent Meningococcal Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 66. Global Quadrivalent Meningococcal Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 67. Global Quadrivalent Meningococcal Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 68. Global Quadrivalent Meningococcal Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 69. Global Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 70. Global Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 71. Global Quadrivalent Meningococcal Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 72. Global Quadrivalent Meningococcal Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 73. Global Quadrivalent Meningococcal Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 74. Global Quadrivalent Meningococcal Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 75. North America Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 76. North America Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 77. North America Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 78. North America Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 79. North America Quadrivalent Meningococcal Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 80. North America Quadrivalent Meningococcal Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 81. North America Quadrivalent Meningococcal Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 82. North America Quadrivalent Meningococcal Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 83. Europe Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 84. Europe Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 85. Europe Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 86. Europe Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 87. Europe Quadrivalent Meningococcal Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 88. Europe Quadrivalent Meningococcal Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 89. Europe Quadrivalent Meningococcal Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Quadrivalent Meningococcal Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 92. Asia-Pacific Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 93. Asia-Pacific Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 94. Asia-Pacific Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 95. Asia-Pacific Quadrivalent Meningococcal Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 96. Asia-Pacific Quadrivalent Meningococcal Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 97. Asia-Pacific Quadrivalent Meningococcal Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 98. Asia-Pacific Quadrivalent Meningococcal Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 99. South America Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 100. South America Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 101. South America Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 102. South America Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 103. South America Quadrivalent Meningococcal Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 104. South America Quadrivalent Meningococcal Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 105. South America Quadrivalent Meningococcal Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 106. South America Quadrivalent Meningococcal Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 107. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 108. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 109. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 110. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 111. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 112. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 113. Middle East & Africa Quadrivalent Meningococcal Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 114. Middle East & Africa Quadrivalent Meningococcal Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 115. Quadrivalent Meningococcal Vaccine Raw Material
Table 116. Key Manufacturers of Quadrivalent Meningococcal Vaccine Raw Materials
Table 117. Quadrivalent Meningococcal Vaccine Typical Distributors
Table 118. Quadrivalent Meningococcal Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Quadrivalent Meningococcal Vaccine Picture
Figure 2. Global Quadrivalent Meningococcal Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Quadrivalent Meningococcal Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Polysaccharide Vaccine Examples
Figure 5. Conjugate Vaccine Examples
Figure 6. Global Quadrivalent Meningococcal Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Quadrivalent Meningococcal Vaccine Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Global Quadrivalent Meningococcal Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Quadrivalent Meningococcal Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Quadrivalent Meningococcal Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Quadrivalent Meningococcal Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Quadrivalent Meningococcal Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Quadrivalent Meningococcal Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Quadrivalent Meningococcal Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Quadrivalent Meningococcal Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Quadrivalent Meningococcal Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Quadrivalent Meningococcal Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Quadrivalent Meningococcal Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Quadrivalent Meningococcal Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Quadrivalent Meningococcal Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Quadrivalent Meningococcal Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Quadrivalent Meningococcal Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Quadrivalent Meningococcal Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Quadrivalent Meningococcal Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Quadrivalent Meningococcal Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Quadrivalent Meningococcal Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Quadrivalent Meningococcal Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Quadrivalent Meningococcal Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 52. China Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Quadrivalent Meningococcal Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Quadrivalent Meningococcal Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Quadrivalent Meningococcal Vaccine Market Drivers
Figure 73. Quadrivalent Meningococcal Vaccine Market Restraints
Figure 74. Quadrivalent Meningococcal Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Quadrivalent Meningococcal Vaccine in 2022
Figure 77. Manufacturing Process Analysis of Quadrivalent Meningococcal Vaccine
Figure 78. Quadrivalent Meningococcal Vaccine Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. Quadrivalent Meningococcal Vaccine Picture
Figure 2. Global Quadrivalent Meningococcal Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Quadrivalent Meningococcal Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Polysaccharide Vaccine Examples
Figure 5. Conjugate Vaccine Examples
Figure 6. Global Quadrivalent Meningococcal Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Quadrivalent Meningococcal Vaccine Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Global Quadrivalent Meningococcal Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Quadrivalent Meningococcal Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Quadrivalent Meningococcal Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Quadrivalent Meningococcal Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Quadrivalent Meningococcal Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Quadrivalent Meningococcal Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Quadrivalent Meningococcal Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Quadrivalent Meningococcal Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Quadrivalent Meningococcal Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Quadrivalent Meningococcal Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Quadrivalent Meningococcal Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Quadrivalent Meningococcal Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Quadrivalent Meningococcal Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Quadrivalent Meningococcal Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Quadrivalent Meningococcal Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Quadrivalent Meningococcal Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Quadrivalent Meningococcal Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Quadrivalent Meningococcal Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Quadrivalent Meningococcal Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Quadrivalent Meningococcal Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Quadrivalent Meningococcal Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 52. China Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Quadrivalent Meningococcal Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Quadrivalent Meningococcal Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Quadrivalent Meningococcal Vaccine Market Drivers
Figure 73. Quadrivalent Meningococcal Vaccine Market Restraints
Figure 74. Quadrivalent Meningococcal Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Quadrivalent Meningococcal Vaccine in 2022
Figure 77. Manufacturing Process Analysis of Quadrivalent Meningococcal Vaccine
Figure 78. Quadrivalent Meningococcal Vaccine Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
